NEW YORK (GenomeWeb News) – Australian bioseparations products firm NuSep today said that it has signed a letter of intent to acquire US-based mass spectrometry software development firm BioInquire for more than $3 million.

NuSep also said that it has closed a private placement of its shares, raising $830,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."